Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 3
1999 2
2000 1
2001 3
2002 4
2003 1
2004 6
2005 8
2006 12
2007 7
2008 10
2009 9
2010 7
2011 1
2012 9
2013 10
2014 12
2015 9
2016 7
2017 10
2018 6
2019 7
2020 13
2021 8
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

146 results
Results by year
Filters applied: . Clear all
Page 1
Locus coeruleus: a new look at the blue spot.
Poe GR, Foote S, Eschenko O, Johansen JP, Bouret S, Aston-Jones G, Harley CW, Manahan-Vaughan D, Weinshenker D, Valentino R, Berridge C, Chandler DJ, Waterhouse B, Sara SJ. Poe GR, et al. Among authors: weinshenker d. Nat Rev Neurosci. 2020 Nov;21(11):644-659. doi: 10.1038/s41583-020-0360-9. Epub 2020 Sep 17. Nat Rev Neurosci. 2020. PMID: 32943779 Free PMC article. Review.
Cocaine sobers up.
Weinshenker D. Weinshenker D. Nat Med. 2010 Sep;16(9):969-70. doi: 10.1038/nm0910-969. Nat Med. 2010. PMID: 20823878 No abstract available.
Neuroscience: fragile dopamine.
Weinshenker D, Warren ST. Weinshenker D, et al. Nature. 2008 Oct 2;455(7213):607-8. doi: 10.1038/455607a. Nature. 2008. PMID: 18833269 No abstract available.
Selective D2 and D3 receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens.
Manvich DF, Petko AK, Branco RC, Foster SL, Porter-Stransky KA, Stout KA, Newman AH, Miller GW, Paladini CA, Weinshenker D. Manvich DF, et al. Among authors: weinshenker d. Neuropsychopharmacology. 2019 Jul;44(8):1445-1455. doi: 10.1038/s41386-019-0371-2. Epub 2019 Mar 16. Neuropsychopharmacology. 2019. PMID: 30879021 Free PMC article.
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment.
Levey AI, Qiu D, Zhao L, Hu WT, Duong DM, Higginbotham L, Dammer EB, Seyfried NT, Wingo TS, Hales CM, Gámez Tansey M, Goldstein DS, Abrol A, Calhoun VD, Goldstein FC, Hajjar I, Fagan AM, Galasko D, Edland SD, Hanfelt J, Lah JJ, Weinshenker D. Levey AI, et al. Among authors: weinshenker d. Brain. 2022 Jun 30;145(6):1924-1938. doi: 10.1093/brain/awab452. Brain. 2022. PMID: 34919634 Free PMC article. Clinical Trial.
Metabolic effects of the schizophrenia-associated 3q29 deletion.
Pollak RM, Purcell RH, Rutkowski TP, Malone T, Pachura KJ, Bassell GJ, Epstein MP, Dawson PA, Smith MR, Jones DP, Zwick ME, Warren ST, Caspary T, Weinshenker D, Mulle JG. Pollak RM, et al. Among authors: weinshenker d. Transl Psychiatry. 2022 Feb 17;12(1):66. doi: 10.1038/s41398-022-01824-1. Transl Psychiatry. 2022. PMID: 35177588 Free PMC article.
146 results